4-AcO-DALT

4-AcO-DALT
Names
	IUPAC name 3-{2-[Di(prop-2-en-1-yl)amino]ethyl}-1H-indol-4-yl acetate
	Other names 4-Acetyloxy-N,N-diallyltryptamine
Identifiers
CAS Number	1445751-71-2;
3D model (JSmol)	Interactive image;
ChemSpider	32078886;
PubChem CID	119025857;
UNII	2Z8WS8Z4T1;
	InChI InChI=1S/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3 Key: WRHFDIBXZYYCHO-UHFFFAOYSA-N; InChI=1/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3 Key: WRHFDIBXZYYCHO-UHFFFAOYAV;
	SMILES CC(=O)Oc1cccc2c1c(c[nH]2)CCN(CC=C)CC=C;
Properties
Chemical formula	C18H22N2O2
Molar mass	298.386 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

4-Acetyloxy-N,N-diallyltryptamine (or 4-AcO-DALT) is a tryptamine derivative. It has been sold as a designer drug, but little other information is available. It was first officially identified in seized drug samples in 2012.^[1]

References

^ EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)

[1]

See also

References